22nd Congress of EHAが2017/06/22-25の日程でスペインマドリードで開催され、CML-CSGより2演題を図説として報告しました。抄録などの詳細は、それぞれの発表をクリックしてください。
★ E-1465
THE INTRODUCTION OF SECOND-GENERATION TYROSINE KINASE INHIBITORS MAY REDUCE THE PROGNOSTIC IMPACT OF HIGH-RISK PATIENTS ACCORDING TO EUROPEAN TREATMENT AND OUTCOME STUDY (EUTOS) SCORE
○Eriko Sato, Noriyoshi Iriyama, Michihide Tokuhira, Tomoiku Takaku, Maho Ishikawa, Tomonori Nakazato, Kei-ji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Yoshihiro Hatta, Masahiro Kizaki, Norio Komatsu, Norio Asou, Tatsuya Kawaguchi.
★ E-1707
ANALYSIS OF VASCULAR ADVERSE EVENTS IN TKI TREATED JAPANESE CML PATIENTS: RETROSPECTIVE LARGE COHORT STUDY OF CML COOPERATIVE STUDY GROUP
○Isao Fujioka, Tomoiku Takaku, Noriyoshi Iriyama, Michihide Tokuhira, Eriko Sato, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto Hiroyuki Fujita, Norio Asou, Masahiro Kizaki Yoshihiro Hatta, Norio Komatsu, Tatsuya Kawaguch.
